Just seven years after the discovery that a bacterial immune system called CRISPR can edit genomes, academic scientists and companies are testing its ability to cure inherited diseases, to give plants and livestock desirable traits, and to fight insect-borne diseases such as malaria. This session will explore the diverse applications of CRISPR, the scientific and regulatory hurdles it faces, and whether reality can come close to the hype surrounding this still-new technology.